AMITA DESAI: Open Payments
NPI 1477600971 · TRENTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 43 payments from 6 companies in 2025. Trend: 2023 $628 · 2024 $922 · 2025 $752
Food & beverage: $752
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $252 |
| Teva Pharmaceuticals USA, Inc. | 17 | $204 |
| Alkermes, Inc. | 5 | $86 |
| Janssen Pharmaceuticals, Inc | 5 | $81 |
| Neurocrine BioSciences, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
Products named: COBENFY, UZEDY, AUSTEDO XR, ARISTADA, INVEGA SUSTENNA, INGREZZA, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
